BIOHIT OYJ BBIOHIT OYJ BBIOHIT OYJ B

BIOHIT OYJ B

No trades
See on Supercharts
Market capitalization
‪30.83 M‬EUR
‪1.85 M‬EUR
‪13.08 M‬EUR
‪4.72 M‬
Beta (1Y)
0.33

About BIOHIT OYJ B

CEO
Jussi Hahtela
Headquarters
Helsinki
Employees (FY)
46
Founded
1988
ISIN
FI0009005482
FIGI
BBG000BXNJ89
Biohit Oyj engages in the development, manufacture, and market of diagnostic tests and analysis systems. It also offers acetaldehyde binding products, monoclonal antibodies, and instruments. The company was founded by Osmo Suovaniemi in 1988 and is headquartered in Helsinki, Finland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BIOBV is 2.01 EUR — it has decreased by 0.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXHEX exchange BIOHIT OYJ B stocks are traded under the ticker BIOBV.
BIOHIT OYJ B is going to release the next earnings report on Aug 7, 2024. Keep track of upcoming events with our Earnings Calendar.
BIOBV stock is 2.00% volatile and has beta coefficient of 0.33. Check out the list of the most volatile stocks — is BIOHIT OYJ B there?
BIOBV earnings for the last quarter are 0.09 EUR per share, whereas the estimation was 0.05 EUR resulting in a 80.00% surprise. The estimated earnings for the next quarter are 0.02 EUR per share. See more details about BIOHIT OYJ B earnings.
BIOHIT OYJ B revenue for the last quarter amounts to ‪6.50 M‬ EUR despite the estimated figure of ‪5.80 M‬ EUR. In the next quarter revenue is expected to reach ‪5.90 M‬ EUR.
Yes, you can track BIOHIT OYJ B financials in yearly and quarterly reports right on TradingView.
BIOBV stock has fallen by 1.47% compared to the previous week, the month change is a 2.81% rise, over the last year BIOHIT OYJ B has showed a 10.14% increase.
BIOBV net income for the last quarter is ‪500.00 K‬ EUR, while the quarter before that showed ‪1.40 M‬ EUR of net income which accounts for −64.29% change. Track more BIOHIT OYJ B financial stats to get the full picture.
Today BIOHIT OYJ B has the market capitalization of ‪30.53 M‬, it has decreased by 0.49% over the last week.
No, BIOBV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BIOBV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOHIT OYJ B stock right from TradingView charts — choose your broker and connect to your account.
BIOBV reached its all-time high on Feb 9, 2000 with the price of 13.50 EUR, and its all-time low was 0.91 EUR and was reached on Oct 31, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 46.00 employees. See our rating of the largest employees — is BIOHIT OYJ B on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOHIT OYJ B technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOHIT OYJ B stock shows the buy signal. See more of BIOHIT OYJ B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BIOHIT OYJ B future price: according to them, BIOBV price has a max estimate of 2.40 EUR and a min estimate of 2.40 EUR. Read a more detailed BIOHIT OYJ B forecast: see what analysts think of BIOHIT OYJ B and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOHIT OYJ B EBITDA is ‪2.20 M‬ EUR, and current EBITDA margin is 16.86%. See more stats in BIOHIT OYJ B financial statements.